STMN2 and Alzheimer disease: We identified STMN2 and ARHGAP32 as particularly abundant and sensitive TDP-43-driven splicing events in brain tissue, along with an additional 16 novel neurodegeneration-driven splicing events that enhance our understanding of shared pathophysiological mechanisms between AD and FTLD-TDP.